The human cerebral cortex possesses distinct structural and functional features that are not found in the lower species traditionally used to model brain development and disease. Accordingly, considerable attention has been placed on the development of methods to direct pluripotent stem cells to form human brain-like structures termed organoids. However, many organoid differentiation protocols are inefficient and display marked variability in their ability to recapitulate the three-dimensional architecture and course of neurogenesis in the developing human brain. Here, we describe optimized organoid culture methods that efficiently and reliably produce cortical and basal ganglia structures similar to those in the human fetal brain in vivo. Neurons within the organoids are functional and exhibit network-like activities. We further demonstrate the utility of this organoid system for modeling the teratogenic effects of Zika virus on the developing brain and identifying more susceptibility receptors and therapeutic compounds that can mitigate its destructive actions.
Correspondence bnovitch@ucla.edu
In Brief
Cerebral organoids recapitulate many aspects of human corticogenesis and are a useful platform for modeling neurodevelopmental mechanisms and diseases. Watanabe et al. describe enhanced organoid methods and model ZIKV pathology. More susceptibility receptors for ZIKV are identified, and differential effects of various compounds to mitigate ZIKV-induced cytopathy are demonstrated.
INTRODUCTION
The neocortex is a highly conserved region of the CNS that enables complex sensory activities and higher cognitive functions. It is disproportionately enlarged in humans and other primates (Rakic, 2009 ), yet the mechanisms underlying its expansion remain poorly defined. The developing neocortex is organized into distinct inner proliferative progenitor compartments, the ventricular zone (VZ) and the subventricular zone (SVZ), which give rise to outer neuronal layers in the cortical plate (CP). The VZ and SVZ contain various types of neural progenitors: apical radial glial (aRG) cells in the VZ and basal radial glial (bRG) cells, intermediate progenitors (IPs) , and transit amplifying cells in the SVZ. A key contributor to human neocortical growth is an expansion of SVZ progenitors, and defects in this process are thought to underlie a range of neurological disorders (Florio and Huttner, 2014; Sun and Hevner, 2014) . The study of early human brain development is challenging due to ethical and practical considerations. Consequently, attention has been placed on the generation of in vitro models using human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) (collectively hPSCs).
hPSCs have ability to self-renew and differentiate into multiple cell types, and they can self-organize to form three-dimensional (3D) structures with features of tissues in vivo. Initially, CNS development was modeled using adherent radial columnar neuroepithelial cells, termed neural rosettes, derived from mouse embryonic stem cells (ESCs) and hESCs (Ying et al., 2003; Zhang et al., 2001) . It was later found that pluripotent stem cell (PSC)-derived cerebral neuroepithelial cells sequentially generate different classes of neurons, consistent with corticogenesis in vivo, and exhibit multi-layered organization under certain floating aggregate culture conditions (Eiraku et al., 2008; Gaspard et al., 2008) . Several protocols for cerebral organotypic cultures derived from hPSCs, often referred to as organoids, have been established, with improvements in neuronal organization and generation of basal progenitors (Kadoshima et al., 2013; Lancaster et al., 2013; Pas xca et al., 2015) . Organoid techniques have thus opened the door for studies of human-specific developmental features and disease modeling (Bershteyn et al., 2017; Lancaster et al., 2013; Mariani et al., 2015; Qian et al., 2016) .
Although cerebral organoid technology is promising, many challenges remain, including rampant batch-to-batch and lineto-line variability and irreproducibility; irregularities in the timing of neuronal maturation, laminar architecture, and cell diversification; unwanted differentiation into other tissue types; and a paucity of direct comparisons of the organoids to native human tissue. Consequently, there is no standardization of the methods used to create cerebral organoids. To realize the potential of organoid systems, it is essential to establish robust and reproducible methods for neural differentiation into specific brain regions to enrich for cells of interest while excluding unwanted cells that confound downstream molecular analyses and applications such as high-throughput phenotypic and therapeutic screening.
Here, we established a simple, yet efficient and reproducible, cerebral organoid differentiation method in which 80%-90% of structures expressed forebrain markers and displayed characteristic neuroepithelial organization. Unbiased transcriptomic analyses confirmed that these cerebral organoids closely match fetal brain and developmental transitions in vivo up to the second trimester. We further found that augmented stimulation of the STAT3 pathway increased the production of basal progenitors, improved the formation and separation of neuronal layers, and promoted astrogliogenesis. Neurons in the cerebral organoids exhibited action potentials and spontaneous ensemble activities. Finally, we used the organoid platform to model Zika virus (ZIKV)-associated microcephaly, identifying additional susceptibility receptors for ZIKV entry into neural progenitors and molecules that can mitigate ZIKV-induced cytopathy. Collectively, our studies provide the community with a reliable and experimentally validated organoid culture system for investigating the mechanistic details underlying human brain development and disease.
RESULTS

Establishment of Efficient and Reproducible Methods for Generating Cerebral Organoids
To initiate organoid formation, we first adapted methods described by Kadoshima et al. (2013) to generate structures from H9 hESCs ( Figure S1A ). Unlike Kadoshima et al. (2013) , we found that transforming growth factor b (TGF-b), bone morphogenetic protein (BMP), or WNT inhibitors were not required to facilitate neuronal fate commitment. To enable the long-term survival and growth of the cerebral organoids, cultures were maintained under hyperoxic (40% O 2 ) without the use of mechanical spinners employed in other protocols (Lancaster et al., 2013; Qian et al., 2016) . With these parameters, organoids routinely exhibited good structural integrity for more than 150 days in culture.
After 2.5 weeks in vitro, nearly all aggregates expressed the forebrain markers FOXG1 and LHX2 and general neural progenitor markers, such as N-CADHERIN (NCAD), PAX6, and NESTIN ( Figures 1A and 1B) . Neuroepithelial layers formed on the periphery of the structures with apical-out and basal-in polarity, and an apoptotic region in the middle was demarcated by cleaved CASP3 (clCASP3) staining ( Figure 1A ). At 2.5 weeks in vitro, the average size of our cerebral organoids was $3.15 mm, 2-3 times bigger than those reported using other protocols (Bershteyn et al., 2017; Qian et al., 2016) , with marked consistency across nine independent experiments ( Figure 1C ). Between 2.5 and 5 weeks in vitro, the neuroepithelial layers exhibited morphogenetic movements that reversed their apicobasal polarity, resulting in uniform neural rosette-like structures within each aggregate ( Figure 1A ). Similar differentiation results were achieved with other hPSC lines (hESC, UCLA1; hiPSC, hIPS2, and XFiPS) (Figures 1B and S1B and S1C) . We also compared the quality and reproducibility of cortical organoids formed with our approach to those achieved using other reported methods (Lancaster and Knoblich, 2014; Lancaster et al., 2013) . Our approach appeared more consistent in producing cortical progenitors and yielded larger and better organized neuroepithelial rosettes ( Figure S2 ). We further modified the methods described by Kadoshima et al. (2013) Figures S1D, S1G , S1I, and S1J), suggesting that IP and bRG cells are preferentially generated under the B27 media conditions. Next, we assessed how well the organoids exhibit features of human corticogenesis. At 1 week in vitro, the organoids showed relatively uniform expression of neuroectodermal markers such as SOX2, PAX6, and NCAD with no obvious apicobasal polarity, similar to the profile of neuroepithelial cells in vivo at gestational week 4 (Figures S1E and S1F Figures 1F, 1G and S1H). The markers expressed by in vitro week 8 and older organoids were similarly expressed within the gestational week 14 human fetal cortex ( Figures 1H and 1I ), indicating that our organoid system efficiently recapitulates the histological organization and patterned expression of key developmental regulators within the human fetal cortex in vivo.
Generation of Ventral Telencephalic Organoids
We examined whether our methods could be modified through the addition of morphogen signals to systematically generate different brain regions. To mimic the ventralizing activities of Sonic hedgehog, which is essential for the formation of the basal ganglionic eminences (GEs), we pulsed organoids with Smoothened agonist (SAG) at 15-21 days in vitro ( Figure S3A ). Lateral ganglionic eminence (LGE), medial ganglionic eminence (MGE), and caudal ganglionic eminence (CGE) progenitor markers were upregulated in a SAG dose-dependent manner. Exposure to high amounts of SAG (1 mM) led to the expression of the MGE/CGE marker NKX2.1 in $50% of cells at 5 weeks in vitro (Figures S3B-S3E), followed by broad expression of the g-aminobutyric acid (GABAergic) interneuron marker GAD65 in the neuronal layers of in vitro week 8 organoids ( Figures S3F and S3H ). At 10 weeks in vitro, additional interneuron subtype markers such as SOMATOSTATIN, CALRETININ, and NEUROPEPTIDE Y were expressed, though PARVALBUMIN was undetectable (Figures S3F and S3G) . By 14 weeks in vitro, the neurotransmitter GABA was present in many cells ( Figure S3F ). Altogether, these results demonstrate that basal GE-like structures and inhibitory interneurons can be readily generated through the addition of ventral patterning signals to our organoid platform.
Transcriptomic Analyses Confirm that Cerebral Organoids Mimic Many Features of Cortical Development In Vivo
We next used unbiased bioinformatics analyses (Stein et al., 2014) to examine how closely our cerebral organoids recapitulate human fetal cortex gene expression. In this framework, three core transcriptomic analyses were used: (1) CoNTExT, a machine-learning classifier, to identify the developmental maturity and neuroanatomical identity of individual in vitro samples compared to in vivo specimens; (2) transition mapping (TMAP) differential expression analysis to identify which in vitro time points best match in vivo developmental transitions; and (3) weighted gene coexpression network analysis (WGCNA) to identify preserved neurodevelopmental processes.
Hierarchical clustering using the top 5,000 most variable genes showed that replicate samples of organoids primarily grouped by developmental stage rather than across time points (Figure 2A ). CoNTExT confirmed their neuroanatomical identity was cortex ( Figure 2B ), consistent with our immunohistochemical analyses (Figure 1 ). CoNTExT also indicated that in vitro week 5 organoids closely match the early embryonic stage of human brain development (period 1, 6-10 gestational weeks), whereas in vitro week 14 organoids match early mid-fetal stages in the second trimester (period 5, 18-21 gestational weeks) ( Figure 2C ).
TMAP was then used to assess how developmental transitions of the organoids matched in vivo. Differential gene expression analyses between pairs of in vivo and in vitro stages were performed, followed by ranking of the resulting gene lists by p value and calculation of the significance of the overlap between the gene lists using a hypergeometric test ( Figure 2D ). We observed strong concordance between in vitro week 5 versus in vitro week 14 organoids and the transition from embryonic to early mid-fetal cortical developmental periods in vivo (periods 1 to 3-4) (max À log10 (p value) = 545) ( Figure 2D ), consistent with the CoNTExT prediction ( Figure 2C ). We also applied TMAP to compare organoid maturation to the transitions between distinct human fetal cortical laminae in vivo (Figure 2E) , which reflect the differentiation of cortical progenitors into neurons and other cell types. The transition from in vitro week 5 to in vitro week 14 organoids closely matched the transition from the VZ or SVZ to the subplate or CP ( Figure 2E ). Collectively, these data demonstrate remarkable preservation of gene expression programs between the organoids and the human fetal cortex.
Finally, to determine which specific cellular or biochemical processes are most highly replicated in organoids compared to fetal cortices in vivo, we used WGCNA (Langfelder and Horvath, 2008) . WGCNA identified groups of coexpressed genes in prenatal human cortex (periods 1-8) coupled to module preservation analysis (Langfelder et al., 2011) , as implemented in the CoNTExT framework (Stein et al., 2014) . Of the 28 modules defined within the human fetal cortex, at least 14 were conserved in cerebral organoids (preservation Z score R 4) ( Figure 2F ; Table S1 ), including modules related to neural progenitor mitosis, neurogenesis, and gliogenesis (modules 4, 3, 5, and 15); axon guidance, synaptogenesis, and synaptic transmission (modules 2, 8, 11, 14, 20, and 27) ; and RNA processing, DNA repair, and ubiquitin proteolysis (modules 3, 6, and 15). By contrast, modules associated with blood vessel development (module 19) and neuron-microglia interactions (module 10) were not preserved, consistent with the absence of many nonneural cell populations within the organoids.
STAT3 Activation Increases Human-Abundant bRG Cells and Enhances Astrogliogenesis
We next used the organoid system to explore the mechanisms behind the primate-specific abundance of bRG cells. Transcriptional profiling studies for bRG have suggested that elevation of leukemia inhibitory factor receptor (LIFR)/STAT3 signaling may Table S1. contribute to bRG generation in the human cortex (Pollen et al., 2015) . bRG cells in the organoids, defined by characteristic markers including SOX2, PAX6, HOPX, ITGb5, and pVIM; the absence of TBR2; and somatic location within the SVZ, were readily found from 8 weeks in vitro onward ( Figures 1F-1H , 3A-3D, S1I, S1J, and S4A). However, activating phosphorylation (p) of STAT3 was not apparent ( Figure S4A ). The addition of recombinant leukemia inhibitory factor (LIF) to in vitro week 5 organoids strongly elevated pSTAT3 staining and led to both a >3-fold increase in bRG cells and thickening of the SVZ by 12 weeks in vitro .
Because basal progenitor expansion in the SVZ is implicated in the enlargement of superficial neuronal layers in the human cortex (Rakic, 2009) , we examined the organization of the CP in cerebral organoids after LIF application. Irrespective of LIF inclusion, CTIP2 + or TRB1 + lower-layer neurons were distributed throughout the CP. However, with LIF addition, SATB2 + and BRN2 + upper layers were enlarged and more clearly segregated outward in the CP, similar to the distribution of neurons seen in the gestational week 15.5 human fetal CP ( Figures 3F, S4D , and S4E). LIF application also improved the formation of a LAMININ + basement membrane at the outer margin of the organoids ( Figure 3F ). The layered organization of neurons within the organoids persisted up to 22 weeks in culture (the latest time point evaluated), at which time a prominent outer layer of CUX1 + neurons had formed, particularly in the LIF-treated cultures ( Figures 3G and 3H ). Apoptotic cell death was low (Figure 3G) , suggesting that these culture conditions are conducive to long-term neuronal survival. Collectively, these results show that LIF application can enhance the production of bRG and formation of defined upper layers of neurons within the organoids. LIF/STAT3 signaling has also been implicated in promoting astrogliogenesis in the rodent CNS (Fukuda et al., 2007; Nakashima et al., 1999) . Without LIF, astrocytes distinguished by GFAP and HepaCAM staining and characteristic star-shaped morphologies were rare in the CP region of in vitro week 14 organoids ( Figure 3E ). After LIF addition, GFAP + astrocytes were readily found, along with a smaller number of HepaCAM + cells ( Figures 3E and S5A) . We also observed a 30-fold upregulation of GFAP mRNA and increased GFAP protein staining in aRG soma and fibers, most likely reflecting their transition toward astrogliogenesis ( Figures 3E and S5A ). Regardless of LIF presence or absence, we did not detect signs of oligodendrocyte formation ( Figure S4F ). Long-term culture of organoids has previously been shown to result in glial overgrowth (Pas xca et al., 2015; Renner et al., 2017 ), but we did not observe this to be the case in the in vitro week 22 organoids. GFAP + astrocytes constituted $8% of the total cell population, less than that found in the human neonatal brain ($40% GFAP + ) ( Figures S5B and S5C ).
We lastly compared the astrocyte-promoting effects of LIF to other growth factors known to stimulate the STAT3 pathway, including brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) (Ng et al., 2006) . BDNF and GDNF did not appear to alter the number of GFAP cells, though we did detect a slight enhancement in HepaCAM staining, albeit to a lesser extent than that seen with LIF (Figure S5D) . However, the addition of all three factors led to marked upregulation of HepaCAM ( Figure S5D ), suggesting that their actions can be combined to maximally enhance astrogliogenesis.
Neurons in Cerebral Organoids Are Functionally Similar to Their Native Counterparts and Exhibit Spontaneous Network Activities
To determine the physiological properties of cerebral organoid neurons, we conducted patch clamp recordings within slice preparations. Half of all recorded cells (n = 12 of 24) produced tetrodotoxin-sensitive spike trains upon current stimulation (Figures 4A and 4D) . The sodium and potassium currents were then measured in response to current injections. Cells with action potentials (APs) exhibited larger sodium and potassium peak currents compared to those lacking action potentials ( Figures  4B-4D ). We also assessed the intrinsic properties of all neurons, including membrane potential, membrane resistance, capacitance, peak sodium current, and peak potassium current (Figure 4D ; Table S4 ). The values recorded in the organoids were strikingly similar to those previously obtained from slices of human fetal cortex from gestational weeks 16-22 (Moore et al., 2009) . Only peak amplitudes for sodium and potassium currents were larger in organoids. Altogether, these data demonstrate that neurons in cerebral organoids have electrophysiological properties that closely match the profiles of neurons recorded from mid-gestational stages of human fetal cortex, consistent with our immunohistochemical, molecular, and bioinformatics analyses.
Next, we examined whether neurons in the organoids exhibit hallmarks of functional maturity and synaptic connectivity. Many CTIP2 + neurons expressed Ca 2+ /calmodulin-dependent protein kinase 2a (CaMK2a), a kinase associated with calcium signaling and synaptic plasticity, and displayed high levels of SYNAPSIN (SYN) promoter activity driving either Channelrhodopsin2-YFP or the genetically encoded calcium indicator GCaMP6f (Figures 4E-4G 0 ). Punctate staining for the synaptic vesicle-associated transporter VGLUT1 was also found at many axosomatic and axodendritic contacts between neurons in 3D reconstructions (Figures 4G and 4G 0 ). mRNA expression of additional synaptic markers, including SV2A, SYNAPSIN1, and SYNAPTOTAGMIN1, were confirmed by microarray analyses ( Figure S6A ).
To test whether cortical neurons in organoids display network functions, structures were infected with SYN::GCaMP6f adenoassociated viruses, and calcium dynamics were imaged with resonant scanning two-photon microscopy ( Figures 4H and  S6B ) (Golshani et al., 2009) . Many neurons exhibited spontaneous calcium transients typical for AP spiking ( Figure 4H ; Movie S1). Firing rates extracted from such events revealed significantly correlated deconvolved calcium transients in $18% of all neuronal pairs measured (16 pairs out of 14 segmented cells), suggesting partial synchronization ( Figures 4I, 4J, and S6C) . Thus, neurons in the cortical organoids appear to exhibit spontaneous ensemble activities. Figure S6 and Movie S1. See also (Figure 5D ), indicating that ZIKV preferentially infects progenitors. Previous work has suggested that the susceptibility of neural progenitors to ZIKV infection may be due their expression of the AXL tyrosine kinase receptor, a known entry portal for flaviviruses (Nowakowski et al., 2016) . However, more recent studies have found that AXL deletion does not protect these cells from infection (Wells et al., 2016) , suggesting the existence of additional entry receptors. Studies in both skin and placental cells have implicated the AXL-related receptor tyrosine kinases TYRO3 and MER (collectively termed TAM receptors), T cell immunoglobulin and mucin domain (TIM) family receptors, and CD209 as potential candidates (Hamel et al., 2015; Tabata et al., 2016) . In in vitro week 8 cerebral organoids, AXL, TYRO3, MER, and TIM1 were all prominently localized along the apical surface of aRG cells, with additional punctate staining for TYRO3 and MER seen in both the VZ and the SVZ ( Figures 5A and 5C ). The expression of CD209 was undetectable. We confirmed similar distribution of these receptors in the gestational week 15.5 human fetal cortex ( Figures S7B and S7C) . Thus, the susceptibility of cortical progenitors to ZIKV is plausibly explained by their prominent expression of at least 4 entry receptors. We also observed highly infected vesicular structures in the cerebral organoids that were SOX2 and PAX6 negative yet positive for AXL and the choroid plexus epithelial cell marker AQP1 ( Figures 5B  and S7A ). These findings suggest a potential route of ZIKV entry into the CNS from the bloodstream in vivo, given that the highly vascularized choroid plexus secretes cerebrospinal fluid that flows around aRG progenitors, thus exposing them to the virus.
Next, we analyzed the teratogenic effects of ZIKV infection. After 14 dpi, in vitro week 3 cerebral organoids were stained for HOECHST and propidium iodide (PI) to detect cell death. In mock infected organoids, limited cell death was detected in the necrotic core of the structures ( Figure 5E ). ZIKV exposure dramatically increased the intensity and extent of PI staining and reduced the overall size, area, and perimeter of the organoids ( Figures 5E and 5F ). After 14 dpi, 98% of SOX2 + aRG and bRG progenitors, 77% of TBR2 + IPs, and 63% of CTIP2 + neurons were infected with ZIKV ( Figures 5G and 5H ). Apoptotic death was widespread and catastrophic, with 69% of the cells positive for clCASP3 ( Figure 5H ). The incidence of cell death was similar within each cell type: 76% SOX2 + progenitors, 72% TBR2 + progenitors, and 69% CTIP2 + neurons.
ZIKV infection can also induce spinal cord injury and encephalitis in newborn mice (Fernandes et al., 2017 ) and has been detected in postmortem human fetal spinal cords (Mlakar et al., 2016) . We accordingly tested whether ZIKV could also infect spinal motor neuron progenitors derived from H9 hESCs using previously described methods (Adams et al., 2015) . After ZIKV exposure, $80% of cells became infected, followed by widespread apoptotic cell death particularly in OLIG2 + motor neuron progenitors ( Figure S7D ). LHX2 + cortical progenitors dissociated from cerebral organoids were similarly infected and killed by ZIKV ( Figure S7E ). These data show that ZIKV has the capacity to broadly infect and destroy neural progenitors throughout the CNS.
ZIKV Infection Activates Innate Immune Responses Leading to Programmed Cell Death
To better understand how ZIKV affects neural progenitors, we examined the transcriptional changes that precede and coincide with the onset of cell death within infected in vitro week 8 cortical organoids using RNA sequencing ( Figure S8 ). At 3 dpi, ZIKV envelope protein was present by immunostaining, but cell death was not seen until 5-7 dpi ( Figures 6A and 6B ). Gene ontology (GO) analyses showed that genes associated with innate immune responses, such as interferon-a, interferon-b, ISG15-protein conjugation, and regulation of viral entry, were all highly upregulated at 3 dpi ( Figure 6C ; Table S2 ). However, genes associated with neural development, differentiation, and morphogenesis were suppressed ( Figure 6C ; Tables S2 and S3) , consistent with the decreased expression of neural markers and reductions in organoid size seen after ZIKV exposure ( Figure 5 ). By 5 dpi, genes associated with the unfolded protein response and apoptotic signaling pathways became highly upregulated, while genes associated with DNA replication, cell-cycle progression, and mitosis were downregulated ( Figure 6C ; Tables S2 and S3) . Among the 50 genes most upregulated at 3 and 5 dpi, $28% were implicated with immune system activation and function, including several chemokines and cytokines (Table S2 ). These data support the view that ZIKV can directly and indirectly trigger inflammatory responses, leading to neurodegeneration.
Identification of Drugs that Mitigate the Teratogenic Effects of ZIKV Infection on Cortical Development
Although most genes activated by ZIKV infection are known to activate inflammation, $32% of the induced genes were associated with antiviral activities (Table S2) . Of note was cholesterol 25-hydroxylase (CH25H), which encodes an enzyme capable of broadly protecting cells from viral infection (Liu et al., 2013) . CH25H converts cholesterol to 25-hydroxycholesterol (25HC), a soluble factor that blocks viral entry by inhibiting membrane fusion (Liu et al., 2013) . The therapeutic potential for 25HC has been further demonstrated through our recent studies showing that administration to adult non-human primates and mice can reduce viremia and block ZIKV-induced fetal microcephaly when administered during pregnancy (Li et al., 2017) . Because 25HC is a natural defense protein against several viruses, we tested whether this mechanism could be augmented to alleviate ZIKV-induced cytopathy. Addition of 2.5 mM 25HC to the organoid cultures reduced ZIKV mRNA within the organoids by $74% and the overall number of ZIKV envelope-positive cells by $72% (Figures 7A, S9A , and S9A 0 ; Table S5 ). However, there was no appreciable rescue of cell death, most likely reflecting mild toxicity seen with sustained exposure of the organoids to 25HC alone ( Figure 7A ).
Next, we tested whether ZIKV entry and associated pathology could be ameliorated by agents targeting the AXL receptor present on neural progenitors. Organoids were pretreated with either R428, a small molecule inhibitor of the AXL tyrosine kinase domain (Tabata et al., 2016) , or anti-AXL antibodies, both of which have previously been shown to block ZIKV entry and/or spread in some cell types (Hamel et al., 2015; Meertens et al., 2017; Retallack et al., 2016) . High levels of R428 had modest effects, reducing ZIKV mRNA levels by $41% and clCASP3 staining to a similar extent, though changes in ZIKV envelope staining were not statistically significant ( Figure 7B ; Table S5 ). Anti-AXL antibody treatment was less effective, showing no significant reduction in ZIKV mRNA levels ( Figures S9B and S9B 0 ; Table S5 ). These results are likely explained by the presence of additional viral entry receptors that we have found are highly expressed by neural progenitors in both organoids and fetal cortex in vivo.
Several studies have reported protective effects of distinct classes of antibiotics in combating flaviviral infection. We tested three candidates, duramycin, ivermectin, and azithromycin. Duramycin is a cyclic peptide approved for veterinary use that is capable of binding to phosphatidylethanolamine residues present in flavivirus virion lipid membrane and thereby blocking their interactions with phosphatidylserine receptors present on target cells, including AXL, TYRO3, MER, and TIM1. Duramycin has shown efficacy in blocking Ebola, Dengue, and West Nile infection in cultured Vero cells (Richard et al., 2015) and ZIKV infection of human placental cells (Tabata et al., 2016) . Ivermectin and azithromycin are U.S. Food and Drug Administration (FDA)-approved lipophilic macrolide antibiotics that modulate microbial peptidyltransferases and protein translation. Ivermectin can also bind and inhibit flavivirus helicases needed for viral replication and block replication of yellow fever, West Nile, Dengue, Japanese encephalitis, and ZIKVs in a range of cell lines (Barrows et al., 2016; Mastrangelo et al., 2012) . Azithromycin appears capable of reducing ZIKV infection of cultured glial cells (Retallack et al., 2016) . Administration of either duramycin or ivermectin to the cortical organoids dramatically reduced ZIKV mRNA (76% and 96%, respectively) and both ZIKV envelope staining (98% and 97% decrease) and clCASP3 staining (81% and 47% decrease) ( Figures 7C, 7D , S9D, and S9D 0 ; Table S5 ). Although ivermectin was highly protective against ZIKV infection, its addition alone led to a small increase in cell death that was not seen with duramycin (Figures 7C and 7D ; Table S5 ). By contrast, azithromycin displayed no significant capacity to reduce ZIKV expression by qRT-PCR or immunostaining ( Figures S9C and  S9C 0 ; Table S5 ). Altogether, these data demonstrate the utility of the cortical organoid system for discriminating among drugs that could mitigate the teratogenic effects of ZIKV infection in the developing human nervous system and identify duramycin and ivermectin as promising leads for further study.
DISCUSSION
Successes and Remaining Challenges in Modeling Human Brain Development In Vitro
The ability of hPSCs to form 3D brain-like structures allows for the investigation of mechanisms underlying human brain development and disease, but as an emergent technology, technical challenges remain. Here, we established a simple yet efficient and reproducible cerebral organoid differentiation method that is applicable across hPSC lines, and we provide side-by-side comparisons to human fetal cortex using immunohistochemical, transcriptomic, and electrophysiological analyses. We further demonstrate the utility of our organoid platform for modeling the basic mechanisms underlying human corticogenesis and disease.
Thus far, two general approaches have been employed to make organoids: directed differentiation into particular brain regions using defined culture media (Kadoshima et al., 2013; Pas xca et al., 2015; Qian et al., 2016) or whole-brain differentiation methods that permit the spontaneous formation of multiple (Table S2 ) and downregulated genes (Table S3 ). Cell color represents the Àlog10 (p value) for overrepresentation of each GO category within upregulated or downregulated genes. See also Figure S8 .
Cell Reports 21, 517-532, October 10, 2017 527 (legend on next page) neural populations (Lancaster et al., 2013) . While the latter approach offers the potential to create brain-like structures with more component parts, it comes at the expense of structural consistency, with higher variability among individual organoids and experiments that can confound disease modeling efforts (Quadrato et al., 2016) . Because no extrinsic factors were used in our differentiation, the nascent neural tissues exhibit a great deal of plasticity, evident by the robust formation of ventral telencephalic structures (MGE or CGE) in response to Sonic Hedgehog (SHH) pathway agonists. GE organoids offer a means to investigate the mechanisms of interneuron differentiation, migration, and circuit formation.
Because our organoid methods do not require special apparatus such as spinning bioreactors, the platform is easily scaled up or down. After aggregates are formed in V-shaped 96-well plates, they can be transferred en masse to bacterial dishes or multi-well plates for testing different media conditions or therapeutic compounds. The stationary nature of our system reduces mechanical damage to the organoids, often seen with growth in spinning bioreactors. In the future, further improvement in largescale production may be achieved by adopting polymer-based 3D sphere culture methods (Otsuji et al., 2014) .
Expansion of bRG Formation and Promotion of Astrogliogenesis through STAT3 Activation
The human cerebral cortex differs from that of lower species, such as rodents, with respect to the expansion of bRG cells and size of the outer SVZ compartment (Florio and Huttner, 2014; Sun and Hevner, 2014) . Because bRG are sparse in rodents, human cortical organoids are an ideal model system for investigating the expansion of bRG. Nevertheless, bRG production is modest in many organoid protocols compared to the fetal cortex, suggesting that in vitro culture conditions may not permit the optimal expansion of these cells.
Analyses of the human fetal cortex have suggested that activation of the LIFR/STAT3 pathway may be a characteristic feature of bRG cell maintenance in vivo (Pollen et al., 2015) . While expression of LIFR and other bRG markers is preserved in organoids, we found little evidence of STAT3 activation. LIF addition markedly expanded the number of bRG cells and the size of the SVZ, enhanced the separation of neurons into deep and superficial layers, established a basal lamina, and preserved organoid structure and neuronal survival to 22 weeks in vitro. LIF also increased the production of astrocytes, consistent with previous reports (Fukuda et al., 2007; Nakashima et al., 1999) .
Although LIFR/STAT3 signaling is not required for bRG cell formation, it appears rate limiting for bRG expansion. The lack of LIF production within the cortical organoids suggests that its origins are other cells that are missing in vitro. Rodent studies have shown that LIF may be maternally supplied and transported to fetal brain tissues through both the vasculature and the cerebrospinal fluid (Simamura et al., 2010) and produced locally by the developing choroid plexus (Gregg and Weiss, 2005) . Brain endothelial cells secrete LIF and can stimulate astrogliogenesis in culture (Mi et al., 2001) , raising the possibility that they could serve a similar function in vivo. Most bRG and IPs reside near blood vessels in the SVZ (Hansen et al., 2010; Stubbs et al., 2009) , suggesting an intimate relationship. Altogether, these findings illustrate both the importance of the interactions of the vasculature and other cell populations within the developing cortex and the need for fetal tissue research to help discover and explore these connections.
ZIKV-Mediated Activation of Innate Immune Responses
The recent worldwide outbreak of ZIKV infection and CZS has sparked efforts to understand how the virus causes fetal brain damage and develop means to circumvent. ZIKV can directly infect neural progenitors and disrupt neural development, leading to reduced organoid growth and overall size, thus recapitulating microcephaly seen in fetuses and infants exposed to the virus. We also found that ZIKV infection and tissue damage extend to other regions of the nervous system that we generated from hPSCs, such as the spinal cord, again modeling some neural pathologies seen in patients.
Susceptibility of neural progenitors to infection has been attributed to the expression of AXL (Nowakowski et al., 2016; Retallack et al., 2016) , but deletion of AXL from hPSCs shows that neural progenitors are still susceptible to ZIKV infection in its absence (Wells et al., 2016) . Our studies implicate additional members of the TAM/TIM family of transmembrane receptors, TYRO3, MER, and TIM1, as likely entry portals, because their expression was largely confined to VZ and SVZ progenitors, along with AXL. Studies in mice further indicate that neither single nor combined deletion of two of the three TAM receptors can alleviate ZIKV infection (Hastings et al., 2017) , suggesting that expression of even a single receptor may render cells susceptible to the virus.
Insights into how ZIKV triggers cell death have emerged from our and others analyses of transcriptional changes that occur in neural cells after infection (Ghouzzi et al., 2016; Tang et al., 2016; Zhang et al., 2016) . Infected cerebral organoids downregulated genes associated with DNA replication, metabolic processes, and cell-cycle progression and upregulated DNA damage response genes such as TP53 and those associated with apoptotic cell death. Aberrant activation of DNA-damage repair pathways has been shown to impede neural progenitor expansion and are the root cause of many genetic forms of human microcephaly (Gilmore and Walsh, 2013; O'Driscoll and Jeggo, 2008) . Thus, the severe reductions in brain size seen after ZIKV exposure likely reflect both ablation of infected neural duramycin n = 7, ivermectin n = 8; clCASP3: 25HC n = 6, R428 n = 3-4, duramycin n = 3-8, ivermectin n = 8-9. See also Figure S9 and Table S5 for statistical analysis details.
progenitors and blockade in their proliferative and neurogenic capacities. One-third of the 50 most upregulated genes following ZIKV infection were associated with interferon signaling and innate immune response preceding the onset of cell death. The extent of these responses may be a primary determinant of neural pathology. Studies comparing neural progenitor death in vitro following exposure to either an African strain of ZIKV, which had not previously been associated with neural damage, or a more recently isolated Asian strain of ZIKV, associated with microcephaly, found that the latter elicited a stronger interferon response and TP53 activation, potentially explaining strain-specific pathologies . Elevated interferon levels during fetal and postnatal development are also implicated in neuropsychiatric diseases, including schizophrenia, autism, mental retardation, and Down syndrome (Patterson, 2009; Sullivan et al., 2016) . Therefore, even though infants exposed to ZIKV might escape structural brain defects, their risk for neurodevelopmental and neuropsychiatric disorders may be significantly elevated. Future studies may provide valuable insights into how aberrant neuroimmune activation affects the developing brain beyond microcephaly.
Cerebral Organoids as Models for Anti-ZIKV Therapies
There are no approved therapies or vaccines to combat ZIKV infection and its destructive effect on the developing fetal brain. Neural organoids thus provide an invaluable resource to facilitate drug discovery. One of the first drugs identified as a potential ZIKV treatment, azithromycin, can significantly reduce ZIKV infection of cultured glioma cells (Retallack et al., 2016) yet showed little activity in our organoid platform, suggesting that its protective effects on the fetal brain may be limited. By contrast, ivermectin and duramycin both displayed marked efficacy in reducing ZIKV infection and neural tissue loss. The potency of duramycin may reflect its ability to block multiple viral envelope-phosphatidylserine receptor interactions, particularly those involving TIM1 (Richard et al., 2015) , which we found is prominently expressed by early neural progenitors in vivo, along with TAM family members, and faithfully recapitulated in cortical organoids. Although the predictive value of the organoid system requires further validation, our studies demonstrate its power in singling out therapeutic candidates meriting future investigations.
EXPERIMENTAL PROCEDURES
PSC Culture and Organoid Differentiation hPSC experiments were conducted with prior approval from the University of California, Los Angeles (UCLA) Embryonic Stem Cell Research Oversight (ESCRO) Committee. hPSC lines H9, UCLA1, hIPS2, and XFiPS were obtained from the UCLA Broad Stem Cell Research Center Core and maintained on 0.1% gelatin-coated plates with irradiated mouse embryonic feeders in DMEM/F12 (HyClone) with 20% knockout serum replacement (KSR, Invitrogen), modified Eagle's medium (MEM) non-essential amino acids (NEAAs, Invitrogen), GlutaMAX (Invitrogen), 0.1 mM b-mercaptoethanol (Invitrogen), 100 mg/mL of Primocin (InvivoGen), and 10 ng/mL of fibroblast growth factor 2 (FGF2, Invitrogen). hPSCs were maintained at 5% CO 2 at 37 C with daily media change and were passaged every 6 days at 1:3-1:6 using StemPro EZ Passage tool (Invitrogen). Experiments were performed on cells between passages 40-80 for H9, UCLA1, and hIPS2 and between passages 10-20 for XFiPS.
Cortical organoid differentiation was performed as described (Kadoshima et al., 2013) with several modifications. Briefly, hPSCs were dissociated to single cells and plated into low-attachment V-bottom 96-well plates (Sumitomo Bakelite, MS-9096V) to form aggregates in Glasgow's Minimal Essential Medium (GMEM) (Invitrogen), 20% KSR, NEAA, 100 mg/mL of Primocin, 0.1 mM b-mercaptoethanol, sodium pyruvate (Invitrogen), and 20 mM ROCK inhibitor (BioPioneer) without Wnt and TGF-b inhibitors. Half of the media was changed every 2-3 days. ROCK inhibitor was removed after 6 days. Aggregates were then transferred to a hyperoxygenated incubator at 5% CO 2 and 40% O 2 and maintained in DMEM/F12 with N2 (Invitrogen), GlutaMAX, chemically defined lipid concentrate (CDLC, Invitrogen), and 0.4% methylcellulose (Sigma). Culture media was changed every 2-3 days thereafter. On day 35, organoids were cut in half using Vannas spring scissors (Fine Science Tools) and media was changed to N2B27 media containing DMEM/F12 supplemented with N2, GlutaMAX, CDLC, 0.4% methylcellulose, B27 without vitamin A (Invitrogen), 1% growth factor-reduced Matrigel (Fisher Scientific, CB-40230), and 5 mg/mL of heparin (Sigma). For the FBS method, 10% FBS (Invitrogen) was used in place of B27 without vitamin A. On day 56, organoids were cut in half and transferred to oxygen permeable dishes (Lumox, Sarstedt) containing N2B27 media. Organoids were subsequently cut in half every 2 weeks and routinely sustained for up to 150 days. For STAT3 activation, LIF (Millipore) was added at 2,000 U/mL from day 35 onward. At the end of the experiments, organoids were processed for immunohistochemical and RNA analyses as described in the Supplemental Experimental Procedures. See Table S6 for  key resources and Table S7 for antibody information.
ZIKV Infection
ZIKV strain PRVABC59 was obtained from the United States Centers for Disease Control and Prevention (CDC) and further amplified in Aedes albopictus C6/36 cells. Briefly, C6/36 cells were infected at a MOI of 0.05 for 10 days. Cell culture supernatant was collected, centrifuged at 8,000 3 g for 10 min at 4 C, and frozen in aliquots at À80 C. Supernatants from uninfected C3/36 cells were collected as control media for mock infection. Viral titer was determined to be about 10 7 PFU/mL by standard plaque assay on Vero cells.
For infection, each organoid ($80,000 cells per in vitro week 3 organoid and $150,000 cells per in vitro week 8 organoid) was inoculated with 1:2-1:8 viral stocks diluted in N2-based media (MOI of $0.3 to 3.125) ( Figure S7F ) as previously described (Li et al., 2017) and incubated for 2 hr. Thereafter, viral stocks were further diluted 1:2 with fresh culture media. Organoids were maintained with the diluted virus for 24 hr, and then media containing ZIKV was removed and replaced with fresh culture media. Media was then changed every 2-3 days for the remainder of the experiment. Organoids were collected and analyzed by qRT-PCR and immunohistochemistry at various time points. Details for the administration of anti-ZIKV drugs are described in the Supplemental Experimental Procedures.
DATA AND SOFTWARE AVAILABILITY
All gene expression data reported in our study have been deposited within the Gene Expression Omnibus (GEO) repository and are accessible through the GEO Series accession number GSE104279 (https://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE104279). 
